Piramal Pharma Ltd
NSE: PPLPHARMA BSE: 543635
₹237.76
+4.07 (1.74%)
Sat, 07 Nov 2026, 08:12 pm
Market Cap (in Cr)31133.58
PE Ratio0
Dividend0.06
Health Technology
Pharmaceuticals: Major
24.5KPiramal Pharma Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Interest expense on debt | -1.98B | -3.44B | -4.56B | -4.21B |
| Pretax equity in earnings | — | — | — | — |
| Equity in earnings | 590.30M | 543.30M | 594.90M | 729.30M |
| Total assets | 129.06B | 146.38B | 155.26B | 158.97B |
| Total current assets | 40.67B | 48.35B | 54.64B | 57.97B |
| Cash and short term investments | 3.79B | 7.35B | 6.27B | 5.34B |
| Cash & equivalents | 3.25B | 3.04B | 4.83B | 5.01B |
| Short term investments | 543.20M | 4.31B | 1.45B | 329.10M |
| Total receivables, net | 18.23B | 18.21B | 21.51B | 24.15B |
| Accounts receivable - trade, net | 18.09B | 18.14B | 21.35B | 23.76B |
| Other receivables | 141.90M | 65.40M | 158.90M | 390.10M |
| Total inventory | 13.89B | 16.81B | 22.96B | 24.54B |
| Other current assets, total | 4.07B | 5.22B | 3.25B | 3.15B |
| Total non-current assets | 88.39B | 98.03B | 100.61B | 101.00B |
| Long term investments | 3.41B | 4.00B | 2.85B | 3.04B |
| Note receivable - long term | 1.24B | 1.88B | 451.00M | 328.60M |
| Investments in unconsolidated subsidiaries | 1.80B | 1.70B | 2.05B | 2.27B |
| Other investments | 369.50M | 417.60M | 349.40M | 443.00M |
| Net property/plant/equipment | 37.20B | 44.43B | 48.28B | 50.38B |
| Gross property/plant/equipment | 52.55B | 63.92B | 71.92B | 78.47B |
| Deferred tax assets | 4.06B | 4.65B | 6.01B | 6.12B |
| Net intangible assets | 43.36B | 44.46B | 42.90B | 40.87B |
| Goodwill, net | 10.30B | 11.08B | 11.23B | 11.48B |
| Other intangibles, net | 33.05B | 33.38B | 31.67B | 29.39B |
| Other long term assets, total | 360.40M | 497.60M | 576.80M | 587.60M |
| Short term debt | 14.20B | 21.52B | 21.08B | 15.43B |
| Current portion of LT debt and capital leases | 7.61B | 8.49B | 9.37B | 5.48B |
| Short term debt excl. current portion of LT debt | 6.59B | 13.02B | 11.71B | 9.95B |
| Accounts payable | 10.26B | 11.93B | 15.38B | 15.34B |
| Income tax payable | 716.60M | 35.40M | 403.00M | 96.10M |
| Long term debt | 27.08B | 34.85B | 26.02B | 33.13B |
| Long term debt excl. lease liabilities | 27.08B | 34.85B | 26.02B | 33.13B |
| Total equity | 66.97B | 67.73B | 79.11B | 81.25B |
| Shareholders' equity | 66.97B | 67.73B | 79.11B | 81.25B |
| Common equity, total | 66.97B | 67.73B | 79.11B | 81.25B |
| Other common equity | 6.27B | 8.05B | 8.93B | 10.15B |
| Total debt | 41.28B | 56.37B | 47.10B | 48.56B |
| Net debt | 37.49B | 49.02B | 40.83B | 43.22B |
| Change in accounts receivable | -1.85B | 892.60M | -3.91B | -2.33B |
| Change in taxes payable | — | — | — | — |
| Change in accounts payable | 791.20M | -2.65B | 4.04B | 182.40M |
| Change in other assets/liabilities | -106.00M | 529.50M | 2.85B | -753.80M |
| Sale of fixed assets & businesses | 324.20M | 196.90M | 16.00M | 52.50M |
| Purchase/sale of investments, net | -2.33B | -3.96B | 2.59B | 1.19B |
| Sale/maturity of investments | 14.03B | 8.48B | 19.49B | 20.04B |
| Purchase of investments | -16.36B | -12.44B | -16.90B | -18.85B |
| Other investing cash flow items, total | 0 | -733.10M | -42.50M | 163.00M |
| Issuance/retirement of debt, net | 10.19B | 11.98B | -9.72B | 487.20M |
| Issuance/retirement of long term debt | 6.66B | 8.41B | -6.21B | -8.10B |
| Issuance/retirement of short term debt | 3.53B | 3.57B | -3.50B | 8.59B |
| Issuance/retirement of other debt | — | — | — | — |
| Total cash dividends paid | -500.00M | -670.00M | 0 | -144.70M |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 |
